Pro-Con: Antiobesity Drugs Such as Glucagon-Like Peptide-1 Receptor Agonists Should Be a First-Line Treatment in Idiopathic Intracranial Hypertension.

Saved in:
Bibliographic Details
Title: Pro-Con: Antiobesity Drugs Such as Glucagon-Like Peptide-1 Receptor Agonists Should Be a First-Line Treatment in Idiopathic Intracranial Hypertension.
Authors: Lange MG; Metabolism and Systems Science (MGL, SPM, JM, AJS), School of Medical Sciences, University of Birmingham, Birmingham, United Kingdom; National Institutes for Health and Care Research (NIHR) (MGL, LJH, JM, AJS), Birmingham Biomedical Research Centre, United Kingdom; Valley Hospital Medical Center (AV), Las Vegas, Nevada; Las Vegas Neurology Center (AV), Las Vegas, Nevada; Biomedical Sciences (LJH), School of Infection, Inflammation and Immunology, University of Birmingham, Birmingham, United Kingdom; Department of Neurology (JM, AJS), University Hospitals Birmingham NHS Foundation Trust, Birmingham United Kingdom; Blanton Eye Institute (AL), Houston Methodist Hospital, Houston, Texas; Department of Ophthalmology (AGL), Cullen Eye Institute, Baylor College of Medicine, Houston, Texas; Departments of Ophthalmology, Neurology, and Neurosurgery (AGL), Weill Cornell Medicine, New York, New York; Department of Ophthalmology (AGL), University of Texas MD Anderson Cancer Center, Houston, Texas; Texas A&M College of Medicine (AGL), Bryan, Texas; and Department of Ophthalmology (AGL), The University of Iowa Hospitals and Clinics, Iowa City, Iowa., Vickers A, Hill LJ, Mollan SP, Mitchell J, Sinclair AJ, Lee AG
Source: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society [J Neuroophthalmol] 2026 Mar 01; Vol. 46 (1), pp. 117-127.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9431308 Publication Model: Print Cited Medium: Internet ISSN: 1536-5166 (Electronic) Linking ISSN: 10708022 NLM ISO Abbreviation: J Neuroophthalmol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1536-5166
DOI:10.1097/WNO.0000000000002431